Nuzenio

Study Following Dsmb

Study Following Dsmb news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 7 latest news signals 7 publisher sources 100/100 entity strength

Latest news

DSMB approves dose escalation in PepGen’s FREEDOM2-DM1 study - YahooYahoo · Fri, 07 Aug 2026 10:38:11 GMT Clearmind Medicine reports DSMB approves advancing Phase I/II AUD study - TipRanksTipRanks · Thu, 06 Aug 2026 23:03:09 GMT Clearmind Medicine (Nasdaq: CMND) wins DSMB nod to advance AUD trial - Stock TitanStock Titan · Thu, 06 Aug 2026 20:01:03 GMT PepGen to Advance PGN-EDODM1 Into Highest Dose Cohort in Phase 2 FREEDOM2-DM1 Study Following DSMB Review - BioSpaceBioSpace · Thu, 06 Aug 2026 12:39:14 GMT PepGen advances PGN-EDODM1 into 12.5 mg/kg cohort in Phase 2 FREEDOM2-DM1 trial - BitgetBitget · Thu, 06 Aug 2026 12:22:19 GMT Clearmind Reaches Key Clinical Trial Milestone as DSMB Unanimously Clears Progression in AUD Study - The Manila TimesThe Manila Times · Thu, 06 Aug 2026 12:21:58 GMT PepGen Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights - Business WireBusiness Wire · Thu, 06 Aug 2026 11:32:00 GMT

Timeline

Fri, 07 Aug 2026 10:38:11 GMTDSMB approves dose escalation in PepGen’s FREEDOM2-DM1 study - Yahoo

Thu, 06 Aug 2026 23:03:09 GMTClearmind Medicine reports DSMB approves advancing Phase I/II AUD study - TipRanks

Thu, 06 Aug 2026 20:01:03 GMTClearmind Medicine (Nasdaq: CMND) wins DSMB nod to advance AUD trial - Stock Titan

Thu, 06 Aug 2026 12:39:14 GMTPepGen to Advance PGN-EDODM1 Into Highest Dose Cohort in Phase 2 FREEDOM2-DM1 Study Following DSMB Review - BioSpace

Thu, 06 Aug 2026 12:22:19 GMTPepGen advances PGN-EDODM1 into 12.5 mg/kg cohort in Phase 2 FREEDOM2-DM1 trial - Bitget

Thu, 06 Aug 2026 12:21:58 GMTClearmind Reaches Key Clinical Trial Milestone as DSMB Unanimously Clears Progression in AUD Study - The Manila Times

Related explainers

ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.

Connected entities

DSMB5 live mentions PepGen4 live mentions Phase4 live mentions Clearmind Medicine2 live mentions Phase I2 live mentions II AUD2 live mentions Nasdaq2 live mentions CMND2 live mentions AUD2 live mentions Advance PGN2 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Study Following Dsmb.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

7 distinct publisher/source names are currently connected to this entity page.